期刊文献+
共找到1,871篇文章
< 1 2 94 >
每页显示 20 50 100
Effects of pulmonary surfactant combined with noninvasive positive pressure ventilation in neonates with respiratory distress syndrome
1
作者 Ze-Ning Shi Xin Zhang +2 位作者 Chun-Yuan Du Bing Zhao Shu-Gang Liu 《World Journal of Clinical Cases》 SCIE 2024年第23期5366-5373,共8页
BACKGROUND Neonatal respiratory distress syndrome(NRDS)is one of the most common diseases in neonatal intensive care units,with an incidence rate of about 7%among infants.Additionally,it is a leading cause of neonatal... BACKGROUND Neonatal respiratory distress syndrome(NRDS)is one of the most common diseases in neonatal intensive care units,with an incidence rate of about 7%among infants.Additionally,it is a leading cause of neonatal death in hospitals in China.The main mechanism of the disease is hypoxemia and hypercapnia caused by lack of surfactant AIM To explore the effect of pulmonary surfactant(PS)combined with noninvasive positive pressure ventilation on keratin-14(KRT-14)and endothelin-1(ET-1)levels in peripheral blood and the effectiveness in treating NRDS.METHODS Altogether 137 neonates with respiratory distress syndrome treated in our hospital from April 2019 to July 2021 were included.Of these,64 control cases were treated with noninvasive positive pressure ventilation and 73 observation cases were treated with PS combined with noninvasive positive pressure ventilation.The expression of KRT-14 and ET-1 in the two groups was compared.The deaths,complications,and PaO_(2),PaCO_(2),and PaO_(2)/FiO_(2)blood gas indexes in the two groups were compared.Receiver operating characteristic curve(ROC)analysis was used to determine the diagnostic value of KRT-14 and ET-1 in the treatment of NRDS.RESULTS The observation group had a significantly higher effectiveness rate than the control group.There was no significant difference between the two groups in terms of neonatal mortality and adverse reactions,such as bronchial dysplasia,cyanosis,and shortness of breath.After treatment,the levels of PaO_(2)and PaO_(2)/FiO_(2)in both groups were significantly higher than before treatment,while the level of PaCO_(2)was significantly lower.After treatment,the observation group had significantly higher levels of PaO_(2)and PaO_(2)/FiO_(2)than the control group,while PaCO_(2)was notably lower in the observation group.After treatment,the KRT-14 and ET-1 levels in both groups were significantly decreased compared with the pre-treatment levels.The observation group had a reduction of KRT-14 and ET-1 levels than the control group.ROC curve analysis showed that the area under the curve(AUC)of KRT-14 was 0.791,and the AUC of ET-1 was 0.816.CONCLUSION Combining PS with noninvasive positive pressure ventilation significantly improved the effectiveness of NRDS therapy.KRT-14 and ET-1 levels may have potential as therapeutic and diagnostic indicators. 展开更多
关键词 pulmonary surfactant Non-invasive positive pressure ventilation Neonatal respiratory distress syndrome Keratin-14 ENDOTHELIN-1
在线阅读 下载PDF
PS联合CPAP治疗新生儿呼吸窘迫综合征的效果
2
作者 陈菁菁 《医药前沿》 2025年第6期68-70,共3页
目的观察肺表面活性物质(PS)与持续气道正压通气(CPAP)联合治疗新生儿呼吸窘迫综合征(NRDS)的效果。方法选取2022年1月-2024年1月泗洪医院收治的60例NRDS患儿,采用随机数字表法分为对照组和观察组,每组30例。对照组患儿开展常规CPAP治疗... 目的观察肺表面活性物质(PS)与持续气道正压通气(CPAP)联合治疗新生儿呼吸窘迫综合征(NRDS)的效果。方法选取2022年1月-2024年1月泗洪医院收治的60例NRDS患儿,采用随机数字表法分为对照组和观察组,每组30例。对照组患儿开展常规CPAP治疗,观察组患儿在对照组基础上联合应用PS治疗。治疗结束后,比较治疗有效率、不良反应发生率、机械通气参数[吸入氧分数(FiO2)、呼气末正压(PEEP)]及血气分析指标[pH值、氧分压(PO2)、二氧化碳分压(PCO2)]。结果治疗后,观察组总有效率、pH、PO2高于对照组,不良反应总发生率、PEEP、FiO2、PCO2低于对照组(P<0.05)。结论NRDS采用PS与CPAP相结合的疗法,不仅疗效明显,而且安全可靠,能够改善患儿机械通气参数指标和血气指标。 展开更多
关键词 肺表面活性物质 持续气道正压通气 新生儿呼吸窘迫综合征 并发症 机械通气 血气分析
在线阅读 下载PDF
早期联合应用外源性PS和iNO治疗PPHN的效果
3
作者 赵艳梅 曹孟宸 +2 位作者 王颍源 郭静 康文清 《临床医学研究与实践》 2024年第8期81-84,共4页
目的探讨早期联合应用外源性肺表面活性物质(PS)和吸入一氧化氮(iNO)治疗新生儿持续性肺动脉高压(PPHN)的效果。方法选取2019年1月1日至2021年12月31日收治的100例PPHN患儿为研究对象,按照随机数字表法将其分成对照组和观察组,各50例。... 目的探讨早期联合应用外源性肺表面活性物质(PS)和吸入一氧化氮(iNO)治疗新生儿持续性肺动脉高压(PPHN)的效果。方法选取2019年1月1日至2021年12月31日收治的100例PPHN患儿为研究对象,按照随机数字表法将其分成对照组和观察组,各50例。对照组应用iNO+安慰剂(空气),观察组应用iNO+外源性PS。比较两组的治疗效果。结果治疗前,两组的肺动脉收缩压(PASP)、氧分压(PaO_(2))、二氧化碳分压(PaCO_(2))、pH及氧合指数(OI)比较,差异无统计学意义(P>0.05);治疗24、48 h后,两组的PASP、PaCO_(2)、OI均降低,PaO_(2)及pH均升高,且观察组优于对照组,差异具有统计学意义(P<0.05)。观察组的治愈率明显高于对照组,应用体外氧合膜肺(ECMO)及死亡率低于对照组,呼吸机使用时间及总住院时间短于对照组,差异具有统计学意义(P<0.05);两组的不良反应发生情况比较,差异无统计学意义(P>0.05)。结论早期联合应用外源性PS和iNO可明显改善PPHN患儿的氧合情况、降低PASP,减少呼吸机使用时间、总住院时间、对ECMO需求及死亡率,值得临床推广应用。 展开更多
关键词 肺表面活性物质 吸入一氧化氮 新生儿持续性肺动脉高压
在线阅读 下载PDF
枸橼酸咖啡因辅助PS治疗新生儿呼吸窘迫综合征对血清炎症因子及血气分析的影响分析
4
作者 张娟 钱元原 季卫刚 《中外医疗》 2024年第17期5-8,16,共5页
目的 分析枸橼酸咖啡因辅助肺表面活性物质(Pulmonary Surfactant,PS)治疗新生儿呼吸窘迫综合征(Neonatal Respiratory Distress Syndrome,NRDS)的临床疗效及对患儿血清炎症因子、肺功能的影响。方法 单纯随机选择2020年1月—2023年1月... 目的 分析枸橼酸咖啡因辅助肺表面活性物质(Pulmonary Surfactant,PS)治疗新生儿呼吸窘迫综合征(Neonatal Respiratory Distress Syndrome,NRDS)的临床疗效及对患儿血清炎症因子、肺功能的影响。方法 单纯随机选择2020年1月—2023年1月南通大学附属妇幼保健院儿科收治的80例NRDS患儿为研究对象,按不同治疗方法分为两组,每组40例。对照组采用PS治疗,观察组联合枸橼酸咖啡因辅助治疗,两组均治疗2周。比较两组临床疗效、血清炎性因子、血气指标、治疗效果及并发症发生情况。结果 观察组临床疗效(95.00%)高于对照组,差异有统计学意义(χ^(2)=5.165,P=0.023)。治疗后,观察组C反应蛋白、降钙素原、白细胞计数低于对照组,差异有统计学意义(P均<0.05)。治疗后,观察组pH、动脉血氧分压、氧合指数高于对照组,动脉血二氧化碳分压低于对照组,差异有统计学意义(P均<0.05)。观察组呼吸机使用时间、用氧时间、住院时间均短于对照组,差异有统计学意义(P均<0.05)。观察组呼吸暂停次数少于对照组,差异有统计学意义(P<0.05)。两组并发症总发生率比较,差异无统计学意义(P>0.05)。结论 对NRDS患儿使用枸橼酸咖啡因辅助PS治疗可有效改善患儿血气指标,减轻炎症反应,提高治疗有效率,安全可靠。 展开更多
关键词 呼吸窘迫综合征 肺表面活性物质 枸橼酸咖啡因 炎症因子 血气指标
在线阅读 下载PDF
Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis 被引量:20
5
作者 Yan-yan ZHONG Jin-chun LI +4 位作者 Ya-ling LIU Xiao-bo ZHAO Musa MALE Dong-kui SONG Yan BAI 《Current Medical Science》 SCIE CAS 2019年第3期493-499,共7页
There is uncertain result with regard to the use of inhalation or instillation steroids to prevent bronchopulmonary dysplasia in preterm infants. This meta-analysis was designed to evaluate the efficacy and safety of ... There is uncertain result with regard to the use of inhalation or instillation steroids to prevent bronchopulmonary dysplasia in preterm infants. This meta-analysis was designed to evaluate the efficacy and safety of early airway administration (within 2 days after birth) of corticosteroids and pulmonary surfactant (PS) for preventing bronchopulmonary dysplasia (BPD) in premature infants with neonatal respiratory distress syndrome (NRDS). The related studies were retrieved in PubMed, EMBASE, the Cochrane Library, Clinical Trial, CNKI, Wanfang and VIP Database from inception to August 2018. Two reviewers independently screened the studies to ensure that all patients with diagnosis of NRDS were enrolled to studies within 1 day after birth, assessed the quality of included studies by GRADEpro system and extracted the data for review. The meta-analysis was performed by RevMan 5.2 software. A subgroup analysis about inhaled corticosteroid (ICS) delivery method was made between ICS inhalation subgroup [inhalation of ICS by nebulizer or metered dose inhaler (MDI)] and ICS intratracheal instillation subgroup (PS used as a vehicle). Eight randomized controlled trials were enrolled in the meta-analysis, 5 trials of which stated the randomized method, grouping and blinded method, and the follow-up procedures were reported. GRADEpro system showed high quality of 4 trials (5 articles), and the rest 4 trials had moderate quality. Meta-analysis showed that the incidence of BPD was decreased in ICS group, the relative risk (RR) was 0.56 (95% CI: 0.42-0.76), and similar trends were found in ICS inhalation subgroup and ICS intratracheal instillation subgroup, with the corresponding RR being 0.58 (95% CI: 0.41-0.82) and 0.47 (95% CI: 0.24-0.95) respectively. ICS could also significantly reduce the mortality risk as compared with placebo control group (RR: 0.67;95% CI: 0.45-0.99), with RR of ICS inhalation subgroup and ICS intratracheal instillation subgroup being 0.81 (95% CI: 0.34-1.94) and 0.64 (95% CI: 0.41-0.99) respectively. Moreover, the percentage of infants using PS more than one time was lower in ICS group than in the placebo control group, with the RR and 95% CI being 0.55 (95% CI: 0.45-0.67), and that in ICS intratracheal instillation subgroup lower than in ICS inhalation subgroup (RR: 0.56;95% CI: 0.45-0.69, and RR: 0.35;95% CI:0.08-1.52 respectively). There was no significant difference in the incidence of infection or retinopathy of prematurity and neuro-motor system impairment between ICS group and placebo control group, with the corresponding RR being 0.95 (95% CI:0.59-1.52), 0.92 (95% CI: 0.62-1.38) and 1.13 (95% CI: 0.92-1.39), respectively. It was concluded that early administration of ICS and PS is an effective and safe option for preterm infants with NRDS in preventing BPD and reducing mortality, decreasing the additional PS usage, especially for the ICS intratracheal instillation subgroup. Furthermore, the appropriate dose and duration of ICS, combined use of inhalation or instillation of ICS with PS and the long-term safety of airway administration of corticosteroids need to be assessed in large trials. 展开更多
关键词 CORTICOSTEROID pulmonary surfactant PRETERM infants BRONCHOpulmonary DYSPLASIA neonatal respiratory DISTRESS syndrome META-ANALYSIS
在线阅读 下载PDF
Surfactant Protein B 1580 Polymorphism Is Associated with Susceptibility to Chronic Obstructive Pulmonary Disease in Chinese Han Population 被引量:13
6
作者 胡瑞成 徐永健 张珍祥 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2004年第3期216-218,238,共4页
Summary: Whether surfactant protein B (SP-B)-18A/C and 1580C/T polymorphism were associated with susceptibility to chronic obstructive pulmonary disease (COPD) in Chinese Han population was investigated. After genomi... Summary: Whether surfactant protein B (SP-B)-18A/C and 1580C/T polymorphism were associated with susceptibility to chronic obstructive pulmonary disease (COPD) in Chinese Han population was investigated. After genomic DNA was isolated from blood of COPD smokers and control smokers, the genotypes of SP-B-18A/C and SP-B1580C/T polymorphism loci were determined by polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP) respectively. The results showed that there was significant difference in genotypes distribution frequency of SP-B1580C/T polymorphism locus between COPD smokers and control smokers. C→T mutation rate (including TT homozygote and CT heterozygote) in COPD smokers was higher than in control smokers (57.9 % vs 41.7 %, χ2=4.93, P<0.05), whereas there was no significant difference in genotypes distribution frequency of SP-B1580-18A/C locus between COPD smokers and control smokers. The allele frequency (29.1 %) of SP-B1580-18A/C locus is lower than T allele (70.9 %) in Chinese Han Population, and the distribution was different from that in Mexican, in which, the A and T allele frequencies were 85 % and 15 % respectively. It was concluded that SP-B1580 T allele was probably associated with increased susceptibility to COPD in Chinese Han population; The polymorphism of SP-B-18A/C locus maybe varied with race. 展开更多
关键词 chronic obstructive pulmonary disease surfactant protein B genetics polymorphism
在线阅读 下载PDF
Surfactant Protein A Polymorphism Is Associated with Susceptibility to Chronic Obstructive Pulmonary Disease (COPD) in Chinese Uighur Population 被引量:3
7
作者 关键 刘先胜 +4 位作者 谢俊刚 许西琳 骆树新 王苒 徐永健 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2012年第2期186-189,共4页
This study investigatedexamined the correlation between surfactant protein-A (SP-A) polymorphism and the susceptibility of cvhronic obstructive pulmonary disease (COPD) in Xinjiang Uighurs. Genomic DNA was extracted f... This study investigatedexamined the correlation between surfactant protein-A (SP-A) polymorphism and the susceptibility of cvhronic obstructive pulmonary disease (COPD) in Xinjiang Uighurs. Genomic DNA was extracted from peripheral blood of 194 COPD smokers and 201 healthy smokers of Uighur who were hospitalized in or paid a visit to one of the four Xingjiang-based hospi-tals involved in the study, betweenfrom March 2009 to December 2010. Single nucleotide polymor-phisms (SNPs) were studied on A/G atwithin amino acid aa62 (CCA/CCG rs1136451) and C/T within aa219 (CGG/TGG, rs4253527) in SP-A. Genotypes were determined by using the TaqMan polymerase chain reaction (PCR). Our results showed that genotype frequencies were different be-tween the COPD and normal smokers infor aa62 (χx2=6.852, P=0.033). There were also significant differences in allele genotype frequencies between the COPD and the control and allele G might de-crease the risk COPD (χx2=6.545, P=0.011; OR=0.663; 95% CI: 0.484–0.909). The result suggested We were led to conclude that polymorphism of aa62 (CCA/CCG, rs1136451) of SP-A may be asso-ciated with the susceptibility to COPD in Xingjiang Uighurs. 展开更多
关键词 chronic obstructive pulmonary disease surfactant protein A genetic polymorphism SUSCEPTIBILITY
在线阅读 下载PDF
Expression of Peroxiredoxins and Pulmonary Surfactant Protein A Induced by Silica in Rat Lung Tissue 被引量:7
8
作者 LIU Nan XUE Ling +4 位作者 GUAN Yi LI Qing Zhao CAO Fu Yuan PANG Shu Lan GUAN Wei Jun 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2016年第8期584-588,共5页
Silicosis is one of the most serious occupational diseases in China and dates back to centuries ago. In this study, we successfully established a rat model of silicosis by intratracheal silica injection for 28 days an... Silicosis is one of the most serious occupational diseases in China and dates back to centuries ago. In this study, we successfully established a rat model of silicosis by intratracheal silica injection for 28 days and determined hydroxyproline levels to evaluate collagen metabolism in lung homogenates. Oxidative stress status was evaluated by detecting catalase and glutathione peroxidase activities. 展开更多
关键词 Expression of Peroxiredoxins and pulmonary surfactant Protein A Induced by Silica in Rat Lung Tissue SP Figure
在线阅读 下载PDF
Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome 被引量:7
9
作者 Qing Qing Ping Zha +1 位作者 Li-Ying Dai Yang Wang 《World Journal of Clinical Cases》 SCIE 2023年第25期5878-5886,共9页
BACKGROUND Acute respiratory distress syndrome precipitates is widespread pulmonary injury in impacted individuals,the neonatal respiratory distress syndrome(NRDS),primarily observed in preterm infants,represents a pr... BACKGROUND Acute respiratory distress syndrome precipitates is widespread pulmonary injury in impacted individuals,the neonatal respiratory distress syndrome(NRDS),primarily observed in preterm infants,represents a prevalent critical condition in neonatal clinical settings.AIM To investigate the clinical efficacy of various ventilation strategies combined with pulmonary surfactant(PS)therapy in the treatment of NRDS.METHODS A total of 20 neonates diagnosed with respiratory distress syndrome,admitted between May 2021 and June 2022,were randomly assigned to either a research group or a control group.Neonates in the research group received treatment involving high-frequency oscillatory ventilation(HFOV)in conjunction with PS.In contrast,neonates in the control group were administered either controlled mechanical ventilation or synchronous intermittent mandatory ventilation,combined with PS.Arterial blood samples from the neonates in both groups were collected before treatment,as well as 6 h,12 h,24 h,and 48 h post-treatment.These samples underwent blood gas analysis,with measurements taken for pH value,partial pressures of oxygen(O_(2))and carbon dioxide.Concurrently,data was collected on the duration of ventilator use,length of hospitalization time,O_(2) treatment time,treatment outcomes,and complications of the ventilator.RESULTS From 6-48 h post-treatment,both groups demonstrated significant improvements in arterial blood pH and oxygen partial pressure,along with a significant decrease in carbon dioxide partial pressure compared to pre-treatment values(P<0.05).Although these changes progressed over time,there were no significant differences between the two groups(P>0.05).However,the research group had significantly lower X-ray scores,shorter hospitalization time,and less time on O_(2) therapy compared to the control group(P<0.05).Mortality rates were similar between the two groups(P>0.05),but the research group had a significantly lower incidence of complications(P<0.05).CONCLUSION The integration of HFOV combine with PS has proven to effectively expedite the treatment duration,decrease the occurrence of complications,and secure the therapeutic efficacy in managing NRDS. 展开更多
关键词 Neonatal respiratory distress syndrome pulmonary surfactant Mechanical ventilation Respiratory distress syndrome Acute respiratory distress syndrome
在线阅读 下载PDF
两种不同技术PS给药对NRDS并呼吸困难早产儿肺功能及不良反应的影响 被引量:1
10
作者 叶桂姣 郝艳萍 王莉萍 《中国计划生育学杂志》 2024年第9期2079-2084,2089,共7页
目的:对比不同技术肺表面活性物质(PS)给药联合咖啡因对新生儿呼吸窘迫综合征(NRDS)早产儿肺功能及不良反应的影响。方法:选取2019年8月-2023年8月本院收治的NRDS早产儿,随机数字表以简单随机法分为对照组(n=52)与观察组(n=53),对照组... 目的:对比不同技术肺表面活性物质(PS)给药联合咖啡因对新生儿呼吸窘迫综合征(NRDS)早产儿肺功能及不良反应的影响。方法:选取2019年8月-2023年8月本院收治的NRDS早产儿,随机数字表以简单随机法分为对照组(n=52)与观察组(n=53),对照组予以气管插管-使用肺表面活性物质-拔管技术(INSURE)PS给药联合咖啡因治疗,观察组采用微创肺表面活性物质给药技术(LISA)PS给药联合咖啡因治疗。比较两组治疗后24 h的疗效,患儿达到纠正年龄36周时的肺功能指标[潮气量(VT)、呼吸频率(RR)、分钟通气量(MV)、达峰时间比(TPTEF/TE)、达峰容积比(VPEF/VE)、25%、50%及75%潮气量时的呼气流速(FEF25%、FEF50%、FEF75%)]、治疗前与治疗后24h的呼吸力学指标[气道阻力、静态肺顺应性、内源性呼气末正压(PEEP)]、血气分析值[氧分压(PaO_(2))值、二氧化碳分压(PaCO_(2))值、pH]、患儿接受治疗的各项时间指标(呼吸困难消失时间、无创辅助通气总时间、住院时间)、用药期间不良反应及住院期间发症发生率。结果:治疗24h后,观察组疗效(94.3%)高于对照组(88.8%),患儿达到纠正年龄36周时RR、气道阻力与内源性PEEP低于对照组,MV、TPTEF/TE、VPEF/VE、FEF25%、FEF50%、FEF75%、静态肺顺应性均高于对照组,两组血气分析值部分指标均较治疗前有明显恢复,且观察组PaO_(2)与pH高于对照组,PaCO_(2)低于对照组(均P<0.05)。观察组住院时间(18.63±1.83d)少于对照组(20.57±2.07d)(均P<0.05)。各项不良反应及并发症的发生率两组无差别(P>0.05)。结论:INSURE技术与LISA技术PS给药联合咖啡因对NRDS早产儿均有一定疗效,但LISA技术疗效更好,对早产儿肺功能、呼吸功能及血气值均有良好影响,并能促进患儿康复,用药及住院期间未增加早产儿不良反应及并发症发生。 展开更多
关键词 新生儿呼吸窘迫综合征 早产儿 微创肺表面活性物质给药技术 气管插管-使用肺表面活性物质-拔管技术 肺表面活性物质 咖啡因 肺功能 不良反应
在线阅读 下载PDF
Functional changes of pulmonary surfactant in rats with lung injury induced by endotoxin
11
作者 王基平 张亚霏 《Journal of Medical Colleges of PLA(China)》 CAS 1991年第1期53-56,63,共5页
We studied the functional changes of pulmonary surfactant (PS) in acutelung injury models produced by endotoxin injection (E.coli O<sub>55</sub>B<sub>5</sub>) in rats.The sur-face properties ... We studied the functional changes of pulmonary surfactant (PS) in acutelung injury models produced by endotoxin injection (E.coli O<sub>55</sub>B<sub>5</sub>) in rats.The sur-face properties of the lung lavage liquid and the total phospholipids (TPL) ex-tracted from it were assessed on a modified Wilhelmy film balance.γ-A isothermof the lavage liquid revealed an increase in minimum surface tension and a de-crease in hysteresis area,recruitment index and stability index,whereas that ofTPL extracted from it did not show any change except for hysteresis area.Thesurface activity correlates positively with the TPL content but negatively with thetotal protein content in the lavage liquid.The findings indicated that there was adysfunction of PS in rats with the lung injury induced by endotoxin,suggestingthat the function deficiency of PS might be caused by decreased phospholipidsand increased proteins in the alveoli. 展开更多
关键词 pulmonary surfactant ENDOTOXIN LUNG injury Wilhelmy film balance RATS
在线阅读 下载PDF
Morphofunctional Characteristics of Pulmonary Surfactant System and Its Effect on Immune Cells in Influenza A (H1N1) Pathogenesis
12
作者 A. V. Kovner O. V. Potapova +1 位作者 V. A. Shkurupy A. M. Shestopalov 《Open Journal of Pathology》 2016年第1期1-7,共7页
There is an annual increase of influenza-related SARI cases in winter months. Despite the high relevance of this problem, influenza pathogenesis and the role of surfactant system and its SP-A (surfactant protein A) en... There is an annual increase of influenza-related SARI cases in winter months. Despite the high relevance of this problem, influenza pathogenesis and the role of surfactant system and its SP-A (surfactant protein A) enzyme in antiviral defense remain poorly understood. SP-A activates macrophage M1 polarization and triggers an antiviral response due to the activation of T-cells and dendritic cells. Therefore, surfactant system is an important element of infection protection and a promising therapeutic target. 展开更多
关键词 Influenza A (H1N1) Virus pulmonary surfactant system SP-A M1/M2 Macrophages Antiviral Defense
在线阅读 下载PDF
Correlation of neonatal pulmonary surfactant protein A gene polymorphism with pneumonia susceptibility and inflammatory response
13
作者 Yi He 《Journal of Hainan Medical University》 2017年第12期87-90,共4页
Objective:To study the correlation of neonatal pulmonary surfactant protein A gene polymorphism with pneumonia susceptibility and inflammatory response.Methods:Neonates who were born and diagnosed with pneumonia in Zi... Objective:To study the correlation of neonatal pulmonary surfactant protein A gene polymorphism with pneumonia susceptibility and inflammatory response.Methods:Neonates who were born and diagnosed with pneumonia in Zigong Maternity and Child Healthcare Hospital between September 2015 and February 2017 were selected as pneumonia group, and neonates without infection were selected as control group. SP-A gene rs1059054 and rs1136454 loci polymorphism, the contents of inflammatory cytokines in serum as well as the expression of inflammatory transcription factors in peripheral blood were determined.Results:The constituent ratio of rs1059054 loci CC genotype of pneumonia group was significantly higher than that of control group while the constituent ratio of CT and TT genotypes were significantly lower than those of control group;the constituent ratio of rs1136454 loci AA genotype was significantly lower than that of control group while the constituent ratio of AG and GG genotypes were significantly higher than those of control group. PCT, sTREM1, TNF-α and IL-6 levels in serum as well as RORγt mRNA expression in peripheral blood of pneumonia children with SP-A gene rs1059054 loci CC genotype were significantly higher than those of pneumonia children with CT genotype and TT genotype while SOCS1 and Foxp3 mRNA expression in peripheral blood were significantly lower than those of pneumonia children with CT genotype and TT genotype;PCT, sTREM1, TNF-α and IL-6 levels in serum as well as RORγt mRNA expression in peripheral blood of pneumonia children with SP-A gene rs1136454 loci AA genotype were significantly lower than those of pneumonia children with AG genotype and GG genotype while SOCS1 and Foxp3 mRNA expression in peripheral blood were significantly higher than those of pneumonia children with AG genotype and GG genotype.Conclusion: Neonatal SP-A gene rs1059054 loci CC genotype can increase the pneumonia susceptibility and aggravate inflammatory response, and rs1136454 loci AA genotype can decrease pneumonia susceptibility and relieve inflammatory response. 展开更多
关键词 NEONATAL PNEUMONIA pulmonary surfactant protein A Gene polymorphism INFLAMMATORY response
在线阅读 下载PDF
Study on Pulmonary Surfactant of Sudden Death of Infant
14
作者 宋嘉振 郭思侠 《Journal of Nanjing Medical University》 2000年第2期101-104,共4页
Objective To find the pathogenesis of sudden infant death syndrome (SIDS) from changes of pulmonary surfactant. Methods By means of thin layer chromatography technique, surfactant in whole lung specimens of 10 inf... Objective To find the pathogenesis of sudden infant death syndrome (SIDS) from changes of pulmonary surfactant. Methods By means of thin layer chromatography technique, surfactant in whole lung specimens of 10 infants with SIDS and 10 control infants without SIDS (dead of nonrespiratory diseases) were examined qualitatively and quantitatively. Results Eleven components in pulmonary surfactant were examined qualitatively, including lysophosphatidylcholine, sphingomyelin, phosphatidylcholine, phosphatidylserine, phosphatidylinositol, phosphatidylethanolamine, phosphatidylglycerol, diphosphatidylglycerol, phosphatidic acid, cholesterol and neutral lipids. Quantitative examination showed that the amount of surfactant of whole lung specimens in sudden death group [(8.9±1.0) mg/g wet lung weight] was significantly less than that in control group [(12.6±1.4) mg/g wet lung weight, P<0.01]. Qualitative variance showed that the percentages of phosphatidylcholine (49.4%±2.0%) and phosphatidylglycerol (2.6%±0.7%) decreased markedly in sudden death group compared with those in control group (61.5%±3.0% and 4.3%±1.5%, P<0.01). Conclusion Before death there is serious defect on metabolism of pulmonary surfactant in sudden death infants, with the amount decreasing and the ratio of its components being disturbed, which is one of the important pathogenies of SIDS. 展开更多
关键词 sudden infant death syndrome pulmonary surfactant
在线阅读 下载PDF
Clinical Effect of Sildenafil Combined with Alveolar Surfactant in the Treatment of Neonatal Persistent Pulmonary Hypertension
15
作者 TIAN Bo 《外文科技期刊数据库(文摘版)医药卫生》 2021年第12期1386-1389,共7页
Objective: to investigate the clinical efficacy of sildenafil combined with alveolar surfactant in the treatment of neonatal persistent pulmonary hypertension. Methods: in order to better the content of the research o... Objective: to investigate the clinical efficacy of sildenafil combined with alveolar surfactant in the treatment of neonatal persistent pulmonary hypertension. Methods: in order to better the content of the research on the comparison, this experiment will adopt the way of random number table method (January 2020 to December 2020) persistent pulmonary hypertension after cure in our divided into two groups, 50 cases of alveolar surface active substances in treatment, while in the process of treatment of two groups of patients with drug use is the same, However, there was a certain difference in dose. Twenty-five of these patients were taken as the control group in this study, and in the process of treatment, patients were treated with increased low-dose sildenafil. The remaining 25 patients were selected as the study group and treated with a high dose of sildenafil. Secondly, in the process of the study of the selected patients, the current physical condition of the selected patients should be examined and understood, and the appropriate dose of treatment should be selected for the patients according to their specific conditions. There was no significant difference in arterial blood gas index and PAP level before treatment (P > 0.05), but there was significant difference in each index level after treatment (P > 0.05). Conclusion: the newborn children with persistent pulmonary hypertension using small doses or by a combination of large dose of sildenafil alveolar surface active material treatment, all have certain effect, but large doses used sildenafil, better clinical effect, in children improve arterial blood gas index, PAP levels effect is more outstanding, the combination way to actively promote significance in clinic. 展开更多
关键词 different dose SILDENAFIL alveolar surfactant the newborn persistent pulmonary hypertension CLI
在线阅读 下载PDF
枸橼酸咖啡因注射液联合CPS对NRDS患儿肺功能的影响
16
作者 张瑞 付亚楠 刘雨露 《华夏医学》 CAS 2024年第4期95-100,共6页
目的研究枸橼酸咖啡因注射液联合注射用牛肺表面活性剂(CPS)对新生儿呼吸窘迫综合征(NRDS)患儿潮气呼吸肺功能及血清氧化应激指标的影响。方法选取74例NRDS患儿,根据治疗方案分为对照组(采用CPS)和观察组(采用枸橼酸咖啡因注射液联合CP... 目的研究枸橼酸咖啡因注射液联合注射用牛肺表面活性剂(CPS)对新生儿呼吸窘迫综合征(NRDS)患儿潮气呼吸肺功能及血清氧化应激指标的影响。方法选取74例NRDS患儿,根据治疗方案分为对照组(采用CPS)和观察组(采用枸橼酸咖啡因注射液联合CPS治疗)。比较两组临床疗效、治疗前后血气分析指标、潮气呼吸肺功能指标、血清氧化应激指标及E-选择素(CD62E)水平及并发症发生率。结果观察组临床总有效率高于对照组,差异具有统计学意义(P<0.05);治疗7 d后,观察组PaO_(2)高于对照组,PaCO_(2)低于对照组(P<0.05);治疗7 d后,观察组达峰时间比(TPTEF/TE)、潮气量(VT)、达峰容积比(VPEF/VE)均大于对照组,呼吸频率(RR)低于对照组(P<0.05);与对照组相比,观察组治疗7 d后,血清谷胱甘肽过氧化物酶(GSH-Px)、总抗氧化能力(T-AOC)的水平较高,而E-选择素(CD62E)、丙二醛(MDA)的水平较低(P<0.05);两组并发症总发生率相比,差异无统计学意义(P>0.05)。结论采用枸橼酸咖啡因联合CPS治疗可有效促进NRDS患儿血气分析指标、肺功能改善,缓解氧化应激炎症状态,安全性良好。 展开更多
关键词 枸橼酸咖啡因注射液 牛肺表面活性剂 新生儿呼吸窘迫综合征 潮气呼吸肺功能 氧化应激
在线阅读 下载PDF
咖啡因联合PS、无创呼吸机在早产儿RDS中的应用效果
17
作者 刘瑞 张莹 《中国计划生育学杂志》 2024年第12期2923-2928,共6页
目的:分析枸橼酸咖啡因联合肺表面活性物质(PS)、经鼻持续气道正压通气(nCPAP)治疗呼吸窘迫综合征(RDS)早产儿效果。方法:回顾性分析本院2021年7月-2023年7月收治的RDS早产儿临床资料,从接受PS联合nCPAP治疗的患儿中选取45例纳入常规组... 目的:分析枸橼酸咖啡因联合肺表面活性物质(PS)、经鼻持续气道正压通气(nCPAP)治疗呼吸窘迫综合征(RDS)早产儿效果。方法:回顾性分析本院2021年7月-2023年7月收治的RDS早产儿临床资料,从接受PS联合nCPAP治疗的患儿中选取45例纳入常规组,枸橼酸咖啡因联合PS、nCPAP治疗的患儿中选取40例纳入咖啡因组。比较两组住院时间、用氧时间、呼吸暂停次数及并发症发生情况,分析血气指标及血清相关炎性因子水平变化;比较两组治疗3d时临床疗效。结果:经治疗,咖啡因组住院时间(23.12±2.03d)、总用氧时间(80.14±20.58h)、呼吸暂停数(4.02±0.58次)均低于常规组(25.07±2.69d、106.43±32.61h、7.14±1.03次),两组pH、PaO_(2)水平上升且咖啡因组(7.35±0.10、69.54±9.02mmHg)均高于常规组(7.20±0.05、60.37±8.14mmHg),两组PaCO_(2)水平及血清相关炎性因子指标下降且PaCO_(2)咖啡因组(40.16±5.63mmHg)低于常规组(43.08±6.31mmHg)(均P<0.05);治疗3d时,咖啡因组治疗总有效率(87.5%)高于常规组(68.9%),治疗期间支气管发育不良发生率(5.0%)低于常规组(22.2%)(均P<0.05)。结论:nCPAP治疗RDS患儿采用枸橼酸咖啡因联合PS干预可有效缩短24h呼吸暂停次数及给氧时间,改善血气指标和机体炎症反应,降低BPD发生率,促进患儿康复。 展开更多
关键词 早产儿 呼吸窘迫综合征 肺表面活性物质 枸橼酸咖啡因 临床疗效 并发症
在线阅读 下载PDF
改良INSURE技术治疗早产儿呼吸窘迫综合征的临床效果观察
18
作者 俞玲玲 吴萍 +1 位作者 陆红霞 刘灿萍 《中国社区医师》 2025年第1期57-59,共3页
目的:探讨改良气管插管-肺表面活性物质-拔管(INSURE)技术治疗早产儿呼吸窘迫综合征的临床效果。方法:将2022年7月—2024年7月靖江市人民医院收治的78例呼吸窘迫综合征早产儿以随机数字表法分成两组,每组39例。对照组采用传统INSURE技... 目的:探讨改良气管插管-肺表面活性物质-拔管(INSURE)技术治疗早产儿呼吸窘迫综合征的临床效果。方法:将2022年7月—2024年7月靖江市人民医院收治的78例呼吸窘迫综合征早产儿以随机数字表法分成两组,每组39例。对照组采用传统INSURE技术进行治疗,观察组采用改良INSURE技术进行治疗。比较两组治疗效果。结果:治疗前,两组患儿动脉血氧分压、动脉血二氧化碳分压、pH值相比,无明显差异(P>0.05)。治疗后,两组动脉血氧分压、pH值高于治疗前,动脉血二氧化碳分压低于治疗前,差异有统计学意义(P<0.05);但两组间比较,无明显差异(P>0.05)。观察组患儿肺表面活性物质反流、经皮血氧饱和度<85%发生率低于对照组(P<0.05);两组心动过缓、呼吸暂停发生率相比,无明显差异(P>0.05)。观察组气漏综合征、感染发生率较对照组低(P<0.05);两组支气管肺发育不良、视网膜病变发生率相比,无明显差异(P>0.05)。结论:传统、改良INSURE技术均能改善呼吸窘迫综合征早产儿血气指标,但改良INSURE技术还能降低患儿不良事件、并发症发生率。 展开更多
关键词 气管插管-肺表面活性物质-拔管技术 早产儿 呼吸窘迫综合征
在线阅读 下载PDF
振荡筛网雾化肺表面活性物质给药在新生儿呼吸窘迫综合征气管插管呼吸支持治疗中的应用
19
作者 谢月娥 蒋美兰 +4 位作者 周丽芳 刘远威 曹慧春 唐迎元 李芬 《山东医药》 2025年第1期109-113,共5页
目的探讨振荡筛网雾化肺表面活性物质(PS)在新生儿呼吸窘迫综合征(NRDS)需气管插管呼吸支持患儿中的临床疗效及应用价值,为气管插管下NRDS患儿PS的最佳使用方式提供参考。方法选择需气管插管呼吸支持的NRDS患儿43例,按照PS给药方法分为... 目的探讨振荡筛网雾化肺表面活性物质(PS)在新生儿呼吸窘迫综合征(NRDS)需气管插管呼吸支持患儿中的临床疗效及应用价值,为气管插管下NRDS患儿PS的最佳使用方式提供参考。方法选择需气管插管呼吸支持的NRDS患儿43例,按照PS给药方法分为实验组12例、对照组31例。对照组采用传统方式滴入PS给药,实验组采用振荡筛网雾化PS给药。观察并比较两组PS使用前后1 h内脑氧饱和度、心率及血氧饱和度变化情况以及PS的使用次数、插管次数、有创呼吸机使用时间、无创呼吸机使用时间、空氧时间及总用氧时间,纠正胎龄36周中支气管肺发育不良(BPD)、重度BPD、血流动力学意义的动脉导管未闭(hsPDA)、早产儿视网膜病(ROP)、新生儿坏死性小肠结肠炎(NEC)Ⅱ期及以上、脑室周围-脑室内出血(PIVH)3级及以上、肺出血、肺部漏气发生情况。计算并比较两组BPD患儿有创机械通气、无创辅助通气及空氧混合吸入天数的构成比。结果两组脑氧饱和度下降比例、心率下降比例及血氧饱和度下降比例、PS使用次数、插管次数、有创呼吸机使用时间、无创呼吸机使用时间、总用氧时间以及各并发症发生率比较差异均无统计学意义(P均>0.05)。实验组有创机械通气天数构成比低于对照组(P<0.05)。结论振荡筛网雾化PS可减少进展为BPD的NRDS患儿对有创通气的需求,临床疗效较好且安全性较高。 展开更多
关键词 新生儿呼吸窘迫综合征 肺泡表面活性物质 振荡筛网雾化技术 有创机械通气 早产儿
在线阅读 下载PDF
表面活性剂对PS包覆微米Al粉性能的影响 被引量:4
20
作者 李淑娟 周宗礼 +1 位作者 刘祥萱 王煊军 《火工品》 CAS CSCD 北大核心 2007年第3期14-17,共4页
采用不同表面活性剂对微米Al粉进行表面预处理,运用分散聚合方法使苯乙烯(St)在Al粉表面聚合,获得了铝粉-聚苯乙烯(Al-PS)复合粒子;研究了表面活性剂类型对Al粉及Al-PS复合粒子亲水亲油性能、分散性能的影响;通过UV-VIS、FTIR光谱分别... 采用不同表面活性剂对微米Al粉进行表面预处理,运用分散聚合方法使苯乙烯(St)在Al粉表面聚合,获得了铝粉-聚苯乙烯(Al-PS)复合粒子;研究了表面活性剂类型对Al粉及Al-PS复合粒子亲水亲油性能、分散性能的影响;通过UV-VIS、FTIR光谱分别对PS对Al粉包覆量及Al-PS复合粒子结构进行了测试和表征。结果表明:采用十二烷基磺酸钠(SDS)对Al粉预处理后,Al粉的性能最佳;聚合过程中采用十二烷基苯磺酸钠(DBSB),复合粒子的性能最好。 展开更多
关键词 表面活性剂 ps Al粉 性能 包覆
在线阅读 下载PDF
上一页 1 2 94 下一页 到第
使用帮助 返回顶部